Effect on hematologic risk factors for coronary heart disease of a cholesterol reducing diet

European Journal of Clinical Nutrition

Volumn 61, Issue 4, 2007, Pages 483-492

  Jenkins, D J A ^a,b   Kendall, C W C ^a,b   Nguyen, T H ^a,b   Teitel, J ^a,b   Marchie, A ^a,b   Chiu, M ^b,c   Taha, A Y ^a,b   Faulkner, D A ^a,b   Kemp, T ^d   Wong, J M W ^a,b   de Souza, R ^a,b   Emam, A ^a,b   Trautwein, E A ^e   Lapsley, K G ^f   Holmes, C ^a   Josse, R G ^a,b   Leiter, L A ^a,b   Singer, W ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CANCER CARE ONTARIO   (Canada)

^d Dewsbury and District Hospital   (United Kingdom)

^e UNILEVER RESEARCH VLAARDINGEN   (Netherlands)

^f Almond Board of California   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; PROTEIN P50; SOYBEAN PROTEIN;

ADULT; AGED; ALMOND; ARTICLE; BLOOD CELL COUNT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CHOLESTEROL DIET; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY FIBER; ERYTHROCYTE FRAGILITY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; METABOLIC SYNDROME X; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; RISK REDUCTION; THROMBOCYTE VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL; CHOLESTEROL, DIETARY; CORONARY DISEASE; DIETARY FIBER; ERYTHROCYTE DEFORMABILITY; FEMALE; HEMATOCRIT; HUMANS; HYPERCHOLESTEROLEMIA; MALE; MIDDLE AGED; NEUTROPHILS; PHYTOSTEROLS; PRUNUS; RISK FACTORS; SOYBEAN PROTEINS;

EID: 34247181246     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/sj.ejcn.1602551     Document Type: Article

References (54)

1. Abu-Zeid HA, Chapman JM (1976). The relation between hemoglobin level and the risk for Ischemic heart disease: A prospective study. J Chronic Dis 29, 395-403.
2. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group (2002). The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). JAMA 288, 2998-3007.
3. Arant CB, Wessel TR, Olson MB, Bairey Merz CN, Sopko G, Rogers WJ et al. (2004). Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol 43, 2009-2014.
4. Barbieri M, Ragno E, Benvenuti E, Zito GA, Corsi A, Ferrucci L et al. (2001). New aspects of the insulin resistance syndrome: Impact on haematological parameters. Diabetologia 44, 1232-1237.
5. Corti MC, Gaziano M, Hennekens CH (1997). Iron status and risk of cardiovascular disease. Ann Epidemiol 7, 62-68.
6. Dacie JV, Lewis SM (1995). Practical Haematology 8th edn. Churchill-Livingstone: Edinburgh.
7. Danesh J, Collins R, Appleby P, Peto R (1998). Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 279, 1477-1482.
8. Danesh J, Collins R, Peto R, Lowe GD (2000). Haematocrit, viscosity, erythrocyte sedimentation rate: Meta-analyses of prospective studies of coronary heart disease. Eur Heart J 21, 515-520.
9. De Jong A, Plat J, Mensink R (2004). Plant sterols or stanol consumption does not change osmotic fragility of the erythrocyte. Atherosclerosis 5, 68 (Abstract).
10. Dixon JB, Anderson M, Cameron-Smith D, O'Brien PE (2004). Sustained weight loss in obese subjects has benefits that are independent of attained weight. Obes Res 12, 1895-1902.
11. Dormandy JA, Hoare E, Colley J, Arrowsmith DE, Dormandy TL (1973). Clinical, haemodynamic, rheological, and biochemical findings in 126 patients with intermittent claudication. BMJ 4, 576-581.
12. Dormandy JA (1975). Letter: Hyperviscosity angina. Lancet 1, 679-680.
13. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA et al. (1998). Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: Results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279, 1615-1622.
14. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA (1987). Leukocytes and the risk of ischemic diseases. JAMA 257, 2318-2324.
15. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (2001). Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 285, 2486-2497.
16. Facchini F, Hollenbeck CB, Chen YN, Chen YD, Reaven GM (1992). Demonstration of a relationship between white blood cell count, insulin resistance, and several risk factors for coronary heart disease in women. J Intern Med 232, 267-272.
17. Facchini FS, Carantoni M, Jeppesen J, Reaven GM (1998). Hematocrit and hemoglobin are independently related to insulin resistance and compensatory hyperinsulinemia in healthy, non-obese men and women. Metabolism 47, 831-835.
18. Fink PC, Romer M, Haeckel R, Fateh-Moghadam A, Delanghe J, Gressner AM et al. (1989). Measurement of proteins with the Behring Nephelometer. A multicentre evaluation. J Clin Chem Clin Biochem 27, 261-276.
19. Friedman GD, Klatsky AL, Siegelaub AB (1974). The leukocyte count as a predictor of myocardial infarction. N Engl J Med 290, 1275-1278.
20. Grundy SM, Brewer Jr HB, Cleeman JI, Smith Jr SC, Lenfant C, American Heart Association; National Heart, Lung, and Blood Institute (2004a). Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 109, 433-438.
21. Grundy SM, Cleeman JI, Merz CN, Brewer Jr HB, Clark LT, Hunninghake DB et al. (2004b). National Heart, Lung, and Blood Institute; American College of Cardiology Foundation; American Heart Association. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227-239.
22. Haim M, Boyko V, Goldbourt U, Battler A, Behar S (2004). Predictive value of elevated white blood cell count in patients with preexisting coronary heart disease: The Bezafibrate Infarction Prevention Study. Arch Intern Med 164, 433-439.
23. Heart Prevention Study Collaborative Group (2002). MRC/BHF Heart Protection Study of cholesterol lowering with stravastatin in 20, 536 high-risk individuals: A randomised placebo-controlled trial. Lancet 360, 7-22.
24. Hendriks HFJ, Brink EJ, Meijer GW, Princen HMG, Ntanios FY (2003). Safety of long-term consumption of plant sterol esters-enriched spreads. Eur J Clin Nutr 57, 681-692.
25. Horne BD, Anderson JL, John JM, Weaver A, Bair TL, Jensen KR et al. (2005). Which white blood cell subtypes predict increased cardiovascular risk? J Am Coll Cardiol 45, 1638-1643.
26. Jenkins DJ, Kendall CW, Faulkner D, Vidgen E, Trautwein EA, Parker TL et al. (2002). A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 51, 1596-1604.
27. Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG et al. (2003a). The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism 52, 1478-1483.
28. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R et al. (2003b). Effects of a dietary portfolio of cholesterol-lowering foods vs lovastatin on serum lipids and C-reactive protein. JAMA 290, 502-510.
29. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Josse AR, Wong JM et al. (2005a). Direct comparison of dietary portfolio vs statin on C-reactive protein. Eur J Clin Nutr 59, 851-860.
30. Jenkins DJ, Kendall CW, Marchie A, Faulkner DA, Wong JM, de Souza R et al. (2005b). Direct comparison of a dietary portfolio of cholesterol-lowering foods with a statin in hypercholesterolemic participants. Am J Clin Nutr 81, 380-387.
31. Jenkins DJ, Kendall CW, Faulkner DA, Nguyen T, Kemp T, Marchie A et al. (2006). Assessment of the longer-term effects of a dietary portfolio of cholesterol lowering foods in hypercholesterolemia. Am J Clin Nutr 83, 582-591.
32. Jones PJ, Raeini-Sarjaz M, Jenkins DJ, Kendall CW, Vidgen E, Trautwein EA et al. (2005). Effects of a diet high in plant sterols, vegetable proteins, and viscous fibers (dietary portfolio) on circulating sterol levels and red cell fragility in hypercholesterolemic subjects. Lipids 40, 169-174.
33. Krauss RM, Eckel RH, Howard B, Appel LJ, Daniels SR, Deckelbaum RJ et al. (2000). AHA dietary guidelines revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation 102, 2284-2299.
34. Kroger K, Lindemann M, Kreuzfelder E, Brocker M, Santosa F, Grosse-Wilde H (2003). Effect of atorvastatin and clopidogrel on cellular Immune function. Prostaglandins Leukot Essent Fatty Acids 68, 251-255.
35. Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S et al. (2000). Blood rheology, cardiovascular risk factors, and cardiovascular disease: The West of Scotland Coronary Prevention Study. Thromb Haemost 84, 553-558.
36. Meyers DG, Strickland D, Maloley PA, Seburg JK, Wilson JE, McManus BF (1997). Possible association of a reduction in cardiovascular events with blood donation. Heart 78, 188-193.
37. Naito Y, Konishi C, Ohara N (2000). Blood coagulation and osmolar tolerance of erythrocytes in stroke-prone spontaneously hypertensive rats given rapeseed oil or soybean oil as the only dietary fat. Toxicol Lett 116, 209-215.
38. Rassias AJ, Givan AL, Marrin CA, Whalen K, Pahl J, Yeager MP (2002). Insulin increases neutrophil count and phagocytic capacity after cardiac surgery. Anesth Analg 94, 1113-1119.
39. Ratnayake WM, L'Abbe MR, Mueller R, Hayward S, Plouffe L, Hollywood R et al. (2000). Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J Nutr 130, 1166-1178.
40. Ridker PM, Hennekens CH, Buring JE, Rifai N (2000). C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342, 836-843.
41. SAS (2002-2003). Copyright (c) 2002-2003. SAS Institute Inc.: Cary, NC, USA. SAS (r) 9.1.
42. Satterthwaite (1999). The Test Procedure: Comparing Group Means, Copyright ©1999. SAS Institute Inc.: Cary, NC, USA.
43. Scandinavian Simvastatin Survival Study Group (1994). Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 344, 1383-1389.
44. Sempos CT, Looker AC, Gillum RF, Makuc DM (1994). Body iron stores and the risk of coronary heart disease. N Engl J Med 330, 1119-1124.
45. Sullivan JL (1981). Iron and the sex difference in heart disease risk. Lancet 1, 1293-1294.
46. The Agricultural Research Service (1992). Composition of Foods, Agriculture Handbook No 8. US Department of Agriculture: Washington, DC.
47. Tuomainen TP, Salonen R, Nyyssonen K, Salonen JT (1997). Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland. BMJ 314, 793-794.
48. United States Food and Drug Administration (1999). FDA final rule for food labeling health claims: Soy protein and coronary heart disease. Fed Regist 64, 57699-57733.
49. United States Food and Drug Administration (2000). FDA Authorizes New coronary Heart Disease Health Claim for Plant Sterol and Plant Stanol Esters. US FDA: Washington, DC, Docket Nos. 001-1275, OOP-1276.
50. United States Food and Drug Administration (2002). Food labeling: Health claims; soluble dietary fiber from certain foods and coronary heart disease. Fed Regist (Docket no. 01Q-0313).
51. United States Food and Drug Administration (2003). Food labeling health claims: Nuts and heart disease. Fed Regist (Docket no. 02P-0505).
52. Williams MJ, Poulton R, Williams S (2002). Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women. Atherosclerosis 165, 179-184.
53. Woodward M, Rumley A, Tunstall-Pedoe H, Lowe GD (1999). Associations of blood rheology and interleukin-6 with cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 104, 246-257.
54. Woodward M, Rumley A, Lowe GD, Tunstall-Pedoe H (2003). C-reactive protein: Associations with haematological variables, cardiovascular risk factors and prevalent cardiovascular disease. Br J Haematol 122 135-141.